++
For further information, see CMDT Part 10-32: Atrial Fibrillation
+++
Essentials of Diagnosis
++
Presents as an irregularly irregular heart rhythm on exam and ECG
Two main treatment strategies for long-term management of atrial fibrillation are rate control or rhythm control, although they are not mutually exclusive
Rate control with β-blocker or calcium channel blockers generally required
Restoration of sinus rhythm with electrical cardioversion, antiarrhythmic medications, or catheter ablation
The CHADS2 score and the CHA2DS2-VASc score are risk assessment tools that can guide anticoagulation decisions
+++
General Considerations
++
The most common chronic arrhythmia, affecting approximately 9% of individuals older than age 65
The incidence increases significantly with age starting in the 7th decade of life
Rarely life-threatening
If the ventricular rate is rapid enough, it can precipitate hypotension, myocardial ischemia, or myocardial dysfunction
Approximately 60% of patients with a first episode will revert to sinus rhythm within 24 hours
Substantial portion of the aging population with hypertension has asymptomatic or "subclinical" atrial fibrillation, which is also associated with increased risk of stroke
++
Irregularly irregular pulse (harder to distinguish with more rapid heart rates)
Often occurs paroxysmally before becoming the established rhythm
Older or inactive individuals may have relatively few symptoms
However, some patients are made uncomfortable by the irregular rhythm due to palpitations or fatigue
In patients with heart disease, rheumatic disease, and other valvular heart disease, atrial fibrillation can be caused by
Dilated cardiomyopathy
Atrial septal defect
Hypertension
Coronary heart disease
Thyrotoxicosis
In patients with normal hearts, paroxysmal episodes can be caused by
Pericarditis
Chest trauma
Thoracic or cardiac surgery
Thyroid disorders
Obstructive sleep apnea
Pulmonary disease (pneumonia, pulmonary embolism)
Electrolyte disturbances
Acute alcohol excess or withdrawal
Medications, such as β-adrenergic agonists, inotropes, bisphosphonates, and certain chemotherapeutics
++
ECG
Surface ECG typically demonstrates erratic, disorganized atrial activity between discrete QRS complexes occurring in an irregular pattern
Atrial activity may be very fine and difficult to detect on the ECG, or quite coarse and often mistaken for atrial flutter
Echocardiography
Provides assessment of chamber volumes, left ventricular size and function, or the presence of concomitant valvular heart disease
Should be performed in all patients with a new diagnosis of atrial fibrillation
Transesophageal echocardiography is the most sensitive imaging modality to identify thrombi in the left atrium or left atrial appendage prior to any attempt at chemical or electrical cardioversion
Ambulatory ECG monitoring or event recorders are indicated when paroxysmal atrial fibrillation is suspected
Obtain thyroid-stimulating hormone level to exclude thyrotoxicosis as a potential cause
++